Multiple Ascending Dose Study of the Tau-Directed Monoclonal Antibody BIIB092 in Patients with Progressive Supranuclear Palsy (S27.004)
Year: 2018
Type: article
Study design: Clinical Trial
Source: Neurology
Authors: Adam Boxer, Irfan Qureshi, Michael Grundman, Giridhar S. Tirucherai, Clifford Bechtold, Michael Ahlijanian, Gerry Kolaitis, Lawrence I. Golbe, Lawrence S. Honig, Stuart Isaacson, Murray Grossman, Nikolaus R. McFarland, Irene Litvan, David S. Geldmacher, Tao Xie, Yvette Bordelon, Paul Tuite, Padraig O’Suilleabhain, Theresa Zesiewicz
Institutions: University of California, San Francisco, Bristol-Myers Squibb (United States), Rutgers, The State University of New Jersey, Columbia University Irving Medical Center, Institute for Neurodegenerative Disorders, Institute for Neurodegenerative Diseases, University of Pennsylvania, University of Florida, University of California San Diego, University of Alabama at Birmingham, University of Chicago, University of California, Los Angeles, University of Minnesota, The University of Texas Southwestern Medical Center, University of South Florida
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2808257628